Since accumulated cholesterol in the TME is generated from cancer cells and stromal cells (49, 50), future studies should evaluate the feasibility to target the cholesterol metabolism of cancer cells or stromal cells for cancer therapy rather than CD8+ TILs because of the unfavorable effects of statins on activated CD8+ T cells. Here, CD8A is linked to cancer.